Cubist Systematic Strategies’s Cartesian Therapeutics RNAC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-13,010
| Closed | -$351K | – | 2134 |
|
|
2024
Q2 | $351K | Buy |
+13,010
| New | +$351K | ﹤0.01% | 1001 |
|
|
2023
Q2 | – | Sell |
-609
| Closed | -$25.4K | – | 2896 |
|
|
2023
Q1 | $25.4K | Buy |
+609
| New | +$25.4K | ﹤0.01% | 2610 |
|
|
2022
Q4 | – | Sell |
-2,561
| Closed | -$126K | – | 3538 |
|
|
2022
Q3 | $126K | Buy |
2,561
+588
| +30% | +$28.9K | ﹤0.01% | 3150 |
|
|
2022
Q2 | $78K | Sell |
1,973
-1,112
| -36% | -$44K | ﹤0.01% | 3482 |
|
|
2022
Q1 | $114K | Sell |
3,085
-1,152
| -27% | -$42.6K | ﹤0.01% | 3181 |
|
|
2021
Q4 | $414K | Buy |
4,237
+2,976
| +236% | +$291K | ﹤0.01% | 2586 |
|
|
2021
Q3 | $157K | Sell |
1,261
-1,921
| -60% | -$239K | ﹤0.01% | 2646 |
|
|
2021
Q2 | $399K | Buy |
3,182
+717
| +29% | +$89.9K | ﹤0.01% | 2151 |
|
|
2021
Q1 | $335K | Buy |
2,465
+1,830
| +288% | +$249K | ﹤0.01% | 2192 |
|
|
2020
Q4 | $58K | Buy |
+635
| New | +$58K | ﹤0.01% | 2454 |
|
|
2020
Q3 | – | Sell |
-272
| Closed | -$23K | – | 2613 |
|
|
2020
Q2 | $23K | Buy |
272
+211
| +346% | +$17.8K | ﹤0.01% | 2311 |
|
|
2020
Q1 | $4K | Buy |
+61
| New | +$4K | ﹤0.01% | 2102 |
|
|
2018
Q1 | – | Sell |
-128
| Closed | -$38K | – | 2025 |
|
|
2017
Q4 | $38K | Buy |
+128
| New | +$38K | ﹤0.01% | 1794 |
|